Live Breaking News & Updates on Massachusetts General Hospital Cancer

Stay updated with breaking news from Massachusetts general hospital cancer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Novel BCMA-Directed CAR Anito-Cel Is Highly Effective for Myeloma

BCMA-directed CAR T-cell therapy anitocabtagene autoleucel demonstrated a 76% complete remission rate and 89% negative minimal residual disease in patients with relapsed/refractory multiple myeloma. ....

United States , Matthew Frigault , Harvard Medical School , Hospital Cancer Center , Massachusetts General Hospital Cancer , Kite Therapeutics , Rare Disease , Bcma Directed Car Anito Cel , Cart Cell Therapy ,